Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research
Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

ADELAIDE, AUS, May 17, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia. TetraQ is a NATA-accredited, GLP-recognised rodent... » read more